先天性甲状腺功能减退症患者由于PAX8移码变异伴泌尿生殖畸形。

IF 1 Q4 ENDOCRINOLOGY & METABOLISM
Clinical Pediatric Endocrinology Pub Date : 2022-01-01 Epub Date: 2022-07-12 DOI:10.1297/cpe.2022-0030
Kanako Tanase-Nakao, Koji Muroya, Masanori Adachi, Kiyomi Abe, Tomonobu Hasegawa, Satoshi Narumi
{"title":"先天性甲状腺功能减退症患者由于PAX8移码变异伴泌尿生殖畸形。","authors":"Kanako Tanase-Nakao,&nbsp;Koji Muroya,&nbsp;Masanori Adachi,&nbsp;Kiyomi Abe,&nbsp;Tomonobu Hasegawa,&nbsp;Satoshi Narumi","doi":"10.1297/cpe.2022-0030","DOIUrl":null,"url":null,"abstract":"<p><p>PAX8 is a transcription factor that is expressed in the thyroid gland and kidneys. Monoallelic loss-of-function <i>PAX8</i> variants cause congenital hypothyroidism (CH), and urogenital malformations are infrequent complications seen in less than 10% of <i>PAX8</i> variant carriers. Herein, we report the case of a 3-yr-old female patient with CH who was diagnosed during newborn screening. She was treated with levothyroxine, and she showed normal growth and development at a minimal dose (0.7 µg/kg/d of levothyroxine at 3 yr of age). At 5 mo of age, she visited an emergency department for fever and was incidentally found to have differently sized kidneys by ultrasonography, which was subsequently diagnosed as unilateral multicystic dysplastic kidney. Her serum creatinine and cystatin C levels were normal. Next-generation sequencing-based genetic analysis revealed that the patient was heterozygous for a <i>PAX8</i> frameshift variant (p.Thr320ProfsTer106) and a <i>DUOX2</i> missense variant (p.Arg885Gln). Our patient is the first truncating <i>PAX8</i> variant carrier to have a urogenital malformation with CH. Genetic analysis for <i>PAX8</i> should be considered in patients with CH and urogenital malformations.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/94/cpe-31-250.PMC9637417.pdf","citationCount":"0","resultStr":"{\"title\":\"A patient with congenital hypothyroidism due to a <i>PAX8</i> frameshift variant accompanying a urogenital malformation.\",\"authors\":\"Kanako Tanase-Nakao,&nbsp;Koji Muroya,&nbsp;Masanori Adachi,&nbsp;Kiyomi Abe,&nbsp;Tomonobu Hasegawa,&nbsp;Satoshi Narumi\",\"doi\":\"10.1297/cpe.2022-0030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>PAX8 is a transcription factor that is expressed in the thyroid gland and kidneys. Monoallelic loss-of-function <i>PAX8</i> variants cause congenital hypothyroidism (CH), and urogenital malformations are infrequent complications seen in less than 10% of <i>PAX8</i> variant carriers. Herein, we report the case of a 3-yr-old female patient with CH who was diagnosed during newborn screening. She was treated with levothyroxine, and she showed normal growth and development at a minimal dose (0.7 µg/kg/d of levothyroxine at 3 yr of age). At 5 mo of age, she visited an emergency department for fever and was incidentally found to have differently sized kidneys by ultrasonography, which was subsequently diagnosed as unilateral multicystic dysplastic kidney. Her serum creatinine and cystatin C levels were normal. Next-generation sequencing-based genetic analysis revealed that the patient was heterozygous for a <i>PAX8</i> frameshift variant (p.Thr320ProfsTer106) and a <i>DUOX2</i> missense variant (p.Arg885Gln). Our patient is the first truncating <i>PAX8</i> variant carrier to have a urogenital malformation with CH. Genetic analysis for <i>PAX8</i> should be considered in patients with CH and urogenital malformations.</p>\",\"PeriodicalId\":10678,\"journal\":{\"name\":\"Clinical Pediatric Endocrinology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/94/cpe-31-250.PMC9637417.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Pediatric Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1297/cpe.2022-0030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Pediatric Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1297/cpe.2022-0030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

PAX8是一种在甲状腺和肾脏中表达的转录因子。PAX8变异的单等位基因功能丧失导致先天性甲状腺功能减退症(CH),在不到10%的PAX8变异携带者中,泌尿生殖器畸形是罕见的并发症。在此,我们报告的情况下,3岁的女性患者与CH谁被诊断为新生儿筛查。患者接受左旋甲状腺素治疗,在最小剂量(3岁时左旋甲状腺素0.7µg/kg/d)下显示正常生长发育。5个月大时,因发烧到急诊科就诊,超声检查发现肾脏大小不同,随后诊断为单侧多囊肾发育不良。她的血清肌酐和胱抑素C水平正常。基于下一代测序的遗传分析显示,患者是PAX8移码变体(p.s thr320profster106)和DUOX2错义变体(p.s arg885gln)的杂合。我们的患者是第一个截断PAX8变异携带者有泌尿生殖道畸形合并CH。对于患有CH和泌尿生殖道畸形的患者,应考虑PAX8的遗传分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A patient with congenital hypothyroidism due to a <i>PAX8</i> frameshift variant accompanying a urogenital malformation.

A patient with congenital hypothyroidism due to a <i>PAX8</i> frameshift variant accompanying a urogenital malformation.

A patient with congenital hypothyroidism due to a <i>PAX8</i> frameshift variant accompanying a urogenital malformation.

A patient with congenital hypothyroidism due to a PAX8 frameshift variant accompanying a urogenital malformation.

PAX8 is a transcription factor that is expressed in the thyroid gland and kidneys. Monoallelic loss-of-function PAX8 variants cause congenital hypothyroidism (CH), and urogenital malformations are infrequent complications seen in less than 10% of PAX8 variant carriers. Herein, we report the case of a 3-yr-old female patient with CH who was diagnosed during newborn screening. She was treated with levothyroxine, and she showed normal growth and development at a minimal dose (0.7 µg/kg/d of levothyroxine at 3 yr of age). At 5 mo of age, she visited an emergency department for fever and was incidentally found to have differently sized kidneys by ultrasonography, which was subsequently diagnosed as unilateral multicystic dysplastic kidney. Her serum creatinine and cystatin C levels were normal. Next-generation sequencing-based genetic analysis revealed that the patient was heterozygous for a PAX8 frameshift variant (p.Thr320ProfsTer106) and a DUOX2 missense variant (p.Arg885Gln). Our patient is the first truncating PAX8 variant carrier to have a urogenital malformation with CH. Genetic analysis for PAX8 should be considered in patients with CH and urogenital malformations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Pediatric Endocrinology
Clinical Pediatric Endocrinology ENDOCRINOLOGY & METABOLISM-
CiteScore
2.40
自引率
7.10%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信